INSIDER TRADING

Roivant Sciences Ltd. insider Daniel Allen Gold sells $53.5M in ROIV shares

By Insider Stock Trader Newsroom, Insider Stock Trader: Alerts app2 min readInsider Stock Trader
Roivant Sciences Ltd. insider Daniel Allen Gold sells $53.5M in ROIV shares

An open-market sale between Nov 16 and Nov 17, reported to the SEC on Nov 18, not marked as part of a 10b5-1 plan. By the Insider Stock Trader: Alerts app. Information only, not investment advice.

Daniel Allen Gold, a director of Roivant Sciences Ltd. (ROIV), sold 1,381,762 shares between Nov 16 and Nov 17 at an average price of $38.75, a total of about $54 million, according to a Form 4 filed with the SEC on Nov 18.

The filing does not mark the sale as made under a Rule 10b5-1 trading plan. Three Roivant Sciences Ltd. insiders sold on the open market within 14 days, a pattern known as a cluster sell.

The trade was reported within two business days, as Section 16 requires. It is the 14th insider sale at Roivant Sciences Ltd. reported in the last 90 days.

Details from the SEC filing:

The sale
CompanyRoivant Sciences Ltd. (ROIV)
InsiderDaniel Allen Gold
RoleDirector
TransactionOpen-market sale (code S)
Shares1,381,762
Average price$38.75
Value$53,536,738
Trade datesNov 16 to Nov 17, 2026
Filed with the SECNov 18, 2026, 6:04 PM ET
OwnershipIndirect
Rule 10b5-1 planNot marked in the filing

See the detailed report on this ROIV sale

View the Form 4 on SEC.gov

Follow ROIV for the next insider trade · See where several insiders traded together

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.